Tech Entrepreneur Uses AI to Help Save His Dog

What followed was a remarkable effort that combined artificial intelligence, genetic sequencing, and cutting-edge science to give his dog a fighting chance.
A Race Against Time
Paul Conyngham’s 8-year-old dog, Rosie, was diagnosed with aggressive mast cell cancer. After traditional treatments like chemotherapy and surgery failed to deliver results, he began searching for alternatives.
Using ChatGPT, Conyngham explored potential treatment paths, eventually focusing on immunotherapy — a method that helps the immune system fight disease.
From Code to Customized Treatment
Conyngham partnered with researchers at the UNSW Ramaciotti Centre for Genomics to sequence Rosie’s tumor DNA.
With his background in machine learning, he analyzed the data to identify specific mutations and used that information to design a personalized mRNA cancer vaccine.
The project gained further support from experts at the University of Queensland, helping move the experimental treatment forward.
Breaking Through Barriers
Creating the vaccine was only part of the challenge. Securing approval to administer the treatment proved to be one of the biggest hurdles.
After months of navigating regulatory requirements, Rosie received her first dose in December, followed by additional treatments in the weeks after.
Promising Early Results
The outcome has been encouraging. Rosie’s tumors — once large and life-threatening — have significantly shrunk, and her overall health and energy have improved.
While not considered a cure, the treatment appears to have extended both her lifespan and quality of life.
A Glimpse Into the Future
Researchers say the case raises bigger questions about the future of personalized medicine.
If similar approaches can be refined and scaled, breakthroughs like this could one day influence how cancer is treated — not just in animals, but in humans as well.
RECENT










BE THE FIRST TO KNOW

More Content By
Think American News Staff











